TherapeuticsMD, Inc. (TXMD) Net Margin

Symbol and logo of brand TherapeuticsMD Inc (TXMD)

TherapeuticsMD, Inc. (TXMD) management is currently focusing on stabilizing the business model to protect profits. Meanwhile, demand for women's health medications remains crisis-resistant, ensuring stability. Comparing the company's net profit margins on GURU.Markets, we see that the value of 3.30 aligns with the current metric. Operational activities rely on a network of third-party contract manufacturers in the US with long-term capacity reservations.

TherapeuticsMD (TXMD) - Net Sales Margin from 07/04/2022 to 11/20/2026

Analytical breakdowns for TherapeuticsMD, Inc.

- share price and expert price forecast:
Initial company analysis:TherapeuticsMD Inc, TXMD
Flagship merchandise of TherapeuticsMD

The long-term reliability of TherapeuticsMD, Inc. (TXMD) is determined by its ability to generate real profit after covering all operating and tax expenses. This metric measures the share of the net remainder from every dollar of revenue, reflecting the efficiency of cost management. Analyzing the trajectory of sales margins allows for an assessment of the business's resilience to market fluctuations. Positive dynamics confirm the successful monetization of bioidentical hormone formulations. High margins here indicate the high added value of innovative R&D developments.